Find Faculty
Jeffrey M Saland, MD, MSCR
img_Jeffrey M Saland
PROFESSOR | Pediatrics, Nephrology
email
Are you a patient?
View my
Provider Profile
Specialties
Pediatrics, Pediatric Nephrology and Hypertension

MD, The University of New Mexico School of Medicine

Residency, Pediatrics, Children's National Hospital

Fellowship, Nephrology, University of Texas Southwestern Medical School

Fellowship, Pediatric Nephrology, Mount Sinai Hospital

2013

NY Magazine Best Doctors

59
Publications

Selected Publications

Final Results of the ILLUMINATE-A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1. Yaacov Frishberg, Jeffrey M. Saland, John C. Lieske, Weiming Du, Martin Coenen, Julien Hogan, Anne Laure Sellier-Leclerc, Jaap W. Groothoff, Cristin Kaspar, John M. Gansner, Sally Anne Hulton. Clinical journal of the American Society of Nephrology : CJASN

Outcomes of kidney transplantation in three patients with single large-scale mitochondrial DNA deletion syndromes. Steven H. Lang, Naiga Cottingham, Colleen Donnelly, Sarah Risen, Rossana Malatesta Muncher, Eileen D. Brewer, Jeffery M. Saland, Corrine Benchimol, Fernando Scaglia, Jaya Ganesh. Molecular Genetics and Metabolism

Cytokine-Driven Janus Kinase Signal Transducer and Activator of Transcription Pathway Hyperactivity Predicts Disease Severity in Pediatric FSGS. Carol L. Shen, Ashley Richardson, Marta Martin-Fernandez, Louise Malle, Sofija Buta, Aum Patel, Haylen Rosberger, Jean Lim, Michael Horesh, Jeffrey Saland, Dusan Bogunovic. Kidney360

View All Publications

Kidney Disease in Children

Annenberg Building Floor 14 Room 22

1468 Madison Ave

New York, NY 10029

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Saland during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Alnylam Pharmaceuticals
  • aHUS Foundation
  • Miscellaneous MedicoLegal

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.